BUENA, N.J., May 01, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care Conference. The Conference is taking place May 8-9, 2018 at the Intercontinental Hotel, Boston.
Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Tuesday, May 8th at 12:50 p.m. ET.
The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com


Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Meta Plans $13B AI Data Center Financing in Texas Amid Surging Big Tech Investment
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Apple Explores Intel and Samsung Partnerships to Diversify Chip Supply Chain
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 



